A Phase II Trial of Doxorubicin and Genexol-PM in Patients With Advanced Breast Cancer
NCT01784120
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
48
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Breast Cancer
Interventions
DRUG:
Doxorubicin/Genexol-PM
Sponsor
Gachon University Gil Medical Center